Transgene – L'immunothérapie contre les cancers

TG6002

Deliver chemotherapy directly in the tumor

TG6002 is an oncolytic virus that allows the production of a chemotherapy agent directly in the tumor.

It is based on the patented viral backbone (VVcop TK-RR-) behind Transgene’s Invir.IO™ platform and TG6002 has the FCU1 gene incorporated into its DNA. The expression of FCU1 in tumor cells enables the local conversion of 5-FC, administered orally, into 5-FU, a chemotherapeutic agent commonly used to treat certain cancers.

TG6002, when administered intravenously or via the hepatic artery, replicates selectively in tumor cells, resulting in the local production of 5-FU.

This specific mechanism of action allows for the targeted destruction of the tumor while stimulating the patient’s immune response locally. With its selective mechanism of action, TG6002 could offer a real alternative to chemotherapeutic agents, which due to their systemic administration, have many associated side effects.

Two Phase I/II clinical trials are enrolling patients in Europe.

TG6002 video

Cookie	Duration	Description
__cfduid	1 month	The cookie is used by cdn services like CloudFare to identify individual clients behind a shared IP address and apply security settings on a per-client basis. It does not correspond to any user ID in the web application and does not store any personally identifiable information.
viewed_cookie_policy	1 year	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Cookie	Duration	Description
_ga	1 an	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_gat_gtag_UA_158044571_1	1 minute	Used to persist session state. More information: https://developers.google.com/analytics/devguides/collection/gtagjs/cookie-usage
_gid	1 day	This cookie is installed by Google Analytics. The cookie is used to store information of how visitors use a website and helps in creating an analytics report of how the wbsite is doing. The data collected including the number visitors, the source where they have come from, and the pages viisted in an anonymous form.
vuid	1 years	This domain of this cookie is owned by Vimeo. This cookie is used by vimeo to collect tracking information. It sets a unique ID to embed videos to the website.

menu secondaire

produits : TG6002 teaser

TG6002

Deliver chemotherapy directly in the tumor

TG6002 is an oncolytic virus that allows the production of a chemotherapy agent directly in the tumor.

More information